参考文献/References:
[1]Liu H,Zhou G,Fu X,et al.Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetically silencing of BAX[J].Oncotarget,2017(8):101899-101910.[2]Torre LA,Bray F,Siegel RL,et al.Global Cancer Statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108. [3]Yang J,Lin J,Liu T,et al.Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes[J].Lung Cancer,2014,85(2):110-115. [4]Chen X,Chen Z,Yu S,et al.Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer[J].Clin Cancer Res,2018,24(8):2002-2014.[5]Tomczak K,Czerwińska P,Wiznerowicz M.Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge[J].Contemp Oncol(Pozn),2015,19(1A):A68-A77. [6]Wakeam E,Acuna SA,Leighl NB,et al.Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer:A Propensity-Matched Analysis of Survival[J].Lung Cancer,2017(109):78-88. [7]Zhang Z,Wang S,Ji D,et al.Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma[J].Oncology Reports,2018,39(5):2101-2113.[8]Yang J,Li T,Gao C,et al.FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity[J].FEBS Letters,2014,588(17):3218-3224.[9]Lv J,Fan HX,Zhao XP,et al.Long non-coding RNA Unigene56159 promotes epithelial–mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells[J].Cancer Letters,2016,382(2):166-175.
相似文献/References:
[1]刘治利,葛明建.肺部磨玻璃结节的CT特征与治疗策略进展[J].医学信息,2018,31(11):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
LIU Zhi-li,GE Ming-jian.Advances in CT Features and Treatment Strategies of Pulmonary Ground-glass Nodule[J].Medical Information,2018,31(07):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
[2]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2018,31(07):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[3]葛丽艳,王 琦,朱 宏,等.基于数据挖掘分析GPR35表达对肺腺癌预后的影响[J].医学信息,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
GE Li-yan,WANG Qi,ZHU Hong,et al.The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining[J].Medical Information,2018,31(07):86.[doi:10.3969/j.issn.1006-1959.2018.23.024]
[4]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2019,32(07):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[5]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Medical Information,2019,32(07):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[6]莫俊贤,冼 磊.miRNA-21及PTEN在肺腺癌组织中的表达及意义[J].医学信息,2020,33(09):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
MO Jun-xian,XIAN Lei.Expression and Significance of miRNA-21 and PTEN in Lung Adenocarcinoma[J].Medical Information,2020,33(07):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
[7]张祥鑫,董星星,耿 涛,等.基于与铁死亡相关基因的肺腺癌的新型预后模型构建[J].医学信息,2021,34(15):96.[doi:10.3969/j.issn.1006-1959.2021.15.025]
ZHANG Xiang-xin,DONG Xing-xing,GENG Tao,et al.Construction of A Novel Prognostic Model of Lung Adenocarcinoma Based on Genes Related to Iron Death[J].Medical Information,2021,34(07):96.[doi:10.3969/j.issn.1006-1959.2021.15.025]
[8]林思其,张泽鑫,夏睿琪,等.三种miRNA对肝癌预后预测的生物信息学分析模型[J].医学信息,2022,35(03):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
LIN Si-qi,ZHANG Ze-xin,XIA Rui-qi,et al.A Model of Three miRNA on the Prognosis Prediction of Hepatocellular Carcinomaby Bioinformatics Analysis[J].Medical Information,2022,35(07):81.[doi:10.3969/j.issn.1006-1959.2022.03.019]
[9]李 松,李瑞杰,赵小磊.CDKN2A基因突变与肾细胞癌药物敏感性和预后的关系[J].医学信息,2022,35(16):1.[doi:10.3969/j.issn.1006-1959.2022.16.001]
LI Song,LI Rui-jie,ZHAO Xiao-lei.Relationship Between CDKN2A Gene Mutation and Drug Sensitivity and Prognosis of Renal Cell Carcinoma[J].Medical Information,2022,35(07):1.[doi:10.3969/j.issn.1006-1959.2022.16.001]
[10]李 敖,王玉然,王文浩.基于公共数据库分析自噬相关基因在肺腺癌患者中的预后意义[J].医学信息,2022,35(22):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
LI Ao,WANG Yu-ran,WANG Wen-hao.Prognostic Significance of Autophagy-related Genes in Patients with Lung Adenocarcinoma Based on Public Database Analysis[J].Medical Information,2022,35(07):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
[11]张登才,王若雨,蒋晓煜,等.基于TCGA数据库分析SERPINH1基因在肺腺癌中的表达及意义[J].医学信息,2025,38(01):10.[doi:10.3969/j.issn.1006-1959.2025.01.002]
ZHANG Dengcai,WANG Ruoyu,JIANG Xiaoyu,et al.Expression and Significance of SERPINH1 Gene in Lung AdenocarcinomaBased on TCGA Database[J].Medical Information,2025,38(07):10.[doi:10.3969/j.issn.1006-1959.2025.01.002]